- Home
- RMTI vs DTIL Comparison
RMTI vs DTIL Comparison
Compare RMTI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMTI | DTIL |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | United States | United States |
| Employees | N/A | 67 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1M | 115.5M |
| IPO Year | 1998 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RMTI | DTIL |
|---|---|---|
| Price | $0.84 | $4.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $47.00 |
| AVG Volume (30 Days) | ★ 227.0K | 198.7K |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $75,577,000.00 | $698,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.12 | $34.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.78 | $3.61 |
| 52 Week High | $2.41 | $8.82 |
Technical Indicators
Market Signals| Indicator | RMTI | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 35.10 | 40.17 |
| Support Level | $0.87 | $4.61 |
| Resistance Level | $0.97 | $5.20 |
| Average True Range (ATR) | 0.06 | 0.34 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 3.47 | 22.70 |
Price Performance
Historical ComparisonAbout RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.